{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:44:38Z","timestamp":1773063878098,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10549-025-07712-8","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T03:36:54Z","timestamp":1747193814000},"page":"189-193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Radiation recall dermatitis induced by abemaciclib with successful rechallenge: a case series and literature review"],"prefix":"10.1007","volume":"212","author":[{"given":"Zi-Lu","family":"Yi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei-Bei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Lu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"issue":"2","key":"7712_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1158\/1078-0432.CCR-17-1117","volume":"24","author":"EJ Mun","year":"2018","unstructured":"Mun EJ, Babiker HM, Weinberg U et al (2018) Tumor-treating fields: a fourth modality in cancer treatment. Clin Cancer Res 24(2):266\u2013275","journal-title":"Clin Cancer Res"},{"issue":"2","key":"7712_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1148\/73.2.175","volume":"73","author":"GJ D\u2019Angio","year":"1959","unstructured":"D\u2019Angio GJ, Farber S, Maddock CL (1959) Potentiation of X-ray effects by actinomycin D. Radiology 73(2):175\u2013177","journal-title":"Radiology"},{"key":"7712_CR3","unstructured":"Commissioner O of the. U.S. Food and Drug Administration[EB]\/\/FDA (2023) FDA"},{"issue":"3","key":"7712_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"M Malumbres","year":"2009","unstructured":"Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9(3):153\u2013166","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"7712_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0167-8140(01)00328-0","volume":"59","author":"R Camidge","year":"2001","unstructured":"Camidge R, Price A (2001) Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 59(3):237\u2013245","journal-title":"Radiother Oncol"},{"issue":"9","key":"7712_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1365-4632.2004.02406.x","volume":"43","author":"B Risti\u0107","year":"2004","unstructured":"Risti\u0107 B (2004) Radiation recall dermatitis. Int J Dermatol 43(9):627\u2013631","journal-title":"Int J Dermatol"},{"issue":"7","key":"7712_CR7","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.ejca.2012.12.009","volume":"49","author":"A Levy","year":"2013","unstructured":"Levy A, Hollebecque A, Bourgier C, Loriot Y, Guigay J, Robert C, Delaloge S, Bahleda R, Massard C, Soria JC, Deutsch E (2013) Targeted therapy-induced radiation recall. Eur J Cancer 49(7):1662\u20131668","journal-title":"Eur J Cancer"},{"issue":"2","key":"7712_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1053\/j.seminoncol.2022.04.001","volume":"49","author":"R Bhangoo","year":"2022","unstructured":"Bhangoo R, Cheng T, Petersen M et al (2022) Radiation recall dermatitis: a review of the literature. Semin Oncol 49(2):152\u2013159","journal-title":"Semin Oncol"},{"issue":"41","key":"7712_CR9","doi-asserted-by":"publisher","first-page":"69493","DOI":"10.18632\/oncotarget.17778","volume":"8","author":"R Torres-Guzm\u00e1n","year":"2017","unstructured":"Torres-Guzm\u00e1n R, Calsina B, Hermoso A et al (2017) Preclinical characterization of abemaciclib in hormone receptor positive breast cancer. Oncotarget 8(41):69493\u201369507","journal-title":"Oncotarget"},{"issue":"1","key":"7712_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100939","volume":"14","author":"S David","year":"2021","unstructured":"David S, Ho G, Day D et al (2021) Enhanced toxicity with CDK 4\/6 inhibitors and palliative radiotherapy: non-consecutive case series and review of the literature. Transl Oncol 14(1):100939","journal-title":"Transl Oncol"},{"issue":"16","key":"7712_CR11","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1158\/1078-0432.CCR-17-3575","volume":"24","author":"S Naz","year":"2018","unstructured":"Naz S, Sowers A, Choudhuri R et al (2018) Abemaciclib, a selective CDK4\/6 inhibitor enhances the radiosensitivity of non-small cell lung cancer in vitro and in vivo. Clin Cancer Res 24(16):3994\u20134005","journal-title":"Clin Cancer Res"},{"issue":"1","key":"7712_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1089\/wound.2011.0308","volume":"1","author":"TN Demidova-Rice","year":"2012","unstructured":"Demidova-Rice TN, Durham JT, Herman IM (2012) Wound healing angiogenesis: innovations and challenges in acute and chronic wound healing. Adv Wound Care 1(1):17\u201322","journal-title":"Adv Wound Care"},{"issue":"4","key":"7712_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.hemonc.2020.04.005","volume":"14","author":"A Erjan","year":"2021","unstructured":"Erjan A, Dayyat A (2021) Ribociclib-induced radiation recall dermatitis following stereotactic body radiation therapy: case report and literature review. Hematol Oncol Stem Cell Ther 14(4):353\u2013354","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"2","key":"7712_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10549-021-06169-9","volume":"188","author":"S Chawla","year":"2021","unstructured":"Chawla S, Hill A, Fearfield L et al (2021) Cutaneous toxicities occurring during palbociclib (CDK4\/6 inhibitor) and endocrine therapy in patients with advanced breast cancer: a single-centre experience. Breast Cancer Res Treat 188(2):535\u2013545","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"7712_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s00520-024-08407-4","volume":"32","author":"M Starace","year":"2024","unstructured":"Starace M, Rapparini L, Cedirian S et al (2024) Management of cutaneous adverse events caused by antineoplastic therapies: a single-center experience. Support Care Cancer 32(3):200","journal-title":"Support Care Cancer"},{"issue":"2","key":"7712_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s40257-021-00645-0","volume":"23","author":"E Raschi","year":"2022","unstructured":"Raschi E, Fusaroli M, La Placa M et al (2022) Skin toxicities with cyclin-dependent kinase 4\/6 inhibitors in breast cancer: signals from disproportionality analysis of the FDA adverse event reporting system. Am J Clin Dermatol 23(2):247\u2013255","journal-title":"Am J Clin Dermatol"},{"key":"7712_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1067264","author":"M Pasqualoni","year":"2023","unstructured":"Pasqualoni M, Orlandi A, Palazzo A et al (2023) Case report: Vitiligo-like toxicity due to ribociclib during first-line treatment of metastatic breast cancer: two cases of premature interruption of therapy and exceptional response. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2023.1067264","journal-title":"Front Oncol"},{"issue":"4","key":"7712_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s12282-017-0754-3","volume":"24","author":"K Sekiguchi","year":"2017","unstructured":"Sekiguchi K, Kawamori J, Yamauchi H (2017) Breast reconstruction and postmastectomy radiotherapy: complications by type and timing and other problems in radiation oncology. Breast Cancer 24(4):511\u2013520","journal-title":"Breast Cancer"},{"issue":"5","key":"7712_CR19","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/jso.24028","volume":"112","author":"B El-Sabawi","year":"2015","unstructured":"El-Sabawi B, Sosin M, Carey JN et al (2015) Breast reconstruction and adjuvant therapy: a systematic review of surgical outcomes. J Surg Oncol 112(5):458\u2013464","journal-title":"J Surg Oncol"},{"key":"7712_CR20","doi-asserted-by":"publisher","first-page":"1207896","DOI":"10.3389\/fonc.2023.1207896","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Ye F, Teng Y et al (2023) Radiotherapy dosimetry and radiotherapy related complications of immediate implant-based reconstruction after breast cancer surgery. Front Oncol 13:1207896","journal-title":"Front Oncol"},{"issue":"2","key":"7712_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4048\/jbc.2021.24.e23","volume":"24","author":"H Kim","year":"2021","unstructured":"Kim H, Kang D, Park W et al (2021) Impact of breast reconstruction on biophysical parameters of mammary skin in patients receiving postmastectomy radiotherapy for breast cancer. J Breast Cancer 24(2):206\u2013217","journal-title":"J Breast Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07712-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07712-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07712-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T06:39:24Z","timestamp":1748932764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07712-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["7712"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07712-8","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no financial or non-financial competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}